Grown Rogue International (GRUSF) Operating Expenses (2009 - 2026)
Grown Rogue International's (GRUSF) quarterly Operating Expenses came in at $3.9 million in Q1 2026, down 5.28% year-on-year from $4.1 million in Q1 2025, and up 100.0% quarter-over-quarter from -$9576.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Operating Expenses (2009 - 2026) Analysis & Trends
Grown Rogue International's Operating Expenses history runs 18 years deep, the most recent figure standing at $3.9 million for Q1 2026.
- On a quarterly basis, Operating Expenses fell 5.28% year-over-year to $3.9 million in Q1 2026; TTM through Mar 2026 was -$6359.3 billion, a 315.77% decrease from a year earlier, with the FY2025 full-year figure at $14.7 million, up 11.81% from the prior year.
- Operating Expenses climbed to $3.9 million in Q1 2026 per GRUSF's latest filing, from -$9576.3 billion in the prior quarter.
- Across five years, Operating Expenses topped out at $3217.0 billion in Q3 2025 and bottomed at -$9576.3 billion in Q4 2025.
- The 5-year median for Operating Expenses is $2.8 million (2025), against an average of -$243.7 billion.
- Across the five-year window, Operating Expenses jumped 74.77% in 2025 and slipped 5.28% in 2026, its largest moves.
- Year by year, Operating Expenses stood at $1.8 million in 2022, then grew by 6.49% to $1.9 million in 2023, then soared by 151557942.19% to $2947.2 billion in 2024, then sank by 424.93% to -$9576.3 billion in 2025, then jumped by 100.0% to $3.9 million in 2026.
- Per Business Quant, the three latest GRUSF Operating Expenses figures stand at $3.9 million (Q1 2026), -$9576.3 billion (Q4 2025), and $3217.0 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 455.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | 3.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | -9,576.29 Bn |
| Sep 30, 2025 | 3,217.04 Bn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 4.07 Mn |
| Sep 30, 2024 | 2,947.23 Bn |
| Jun 30, 2024 | 2.37 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 1.94 Mn |
| Oct 31, 2023 | 5.68 Mn |
| Jul 31, 2023 | 3.51 Mn |
| Apr 30, 2023 | 1.77 Mn |
| Jan 31, 2023 | 1.87 Mn |
| Jan 31, 2022 | 1.83 Mn |
| Jul 31, 2021 | 1.53 Mn |
| Apr 30, 2021 | 1.23 Mn |
| Jan 31, 2021 | 1.27 Mn |
| Oct 31, 2020 | 629,483.00 |
| Jul 31, 2020 | 1.27 Mn |
| Apr 30, 2020 | 690,577.00 |